Skip to Main Content
Children's Health | Diseases of the Respiratory Systems, Phase III

Efficacy and Safety of OPN-375 186 ug Twice a Day (BID) in Adolescents with Bilateral Nasal Polyps

What is the purpose of this trial?

To evaluate the efficacy of intranasal administration of OPN-375 186 μg twice a day (BID) versus placebo in adolescents with bilateral nasal polyposis and nasal congestion

  • Trial with
    Optinose
  • Ages
    12 years - 17 years
  • Gender
    Both

Contact Information

For more information about this study, including how to volunteer, contact Lina McKinney

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

  • Last Updated
    04/21/2023
  • Study HIC
    #2000023985